Evaluation of the effect from new criteria for getting a continuous glucose monitor and/or an insulin pump on glycemic level, quality of life and economy.

Chief Physician, Ph.D.
Karoline Schousboe
Steno Diabetes Center Odense, OUH

Project management

Project status	Open



Data collection dates
Start	15.12.2021
End	01.07.2027

Project in numbers

OPEN survey/clinical data
Expected # of participants	6,000
Included # of participants	7,249





Included participants with specimens
Specimens

Evaluation of the effect from new criteria for getting a continuous glucose monitor and/or an insulin pump on glycemic level, quality of life and economy.

Short summary

In the Region of Southern Denmark, new criteria have been introduced for patients with type 1 diabetes regarding treatment with continous glucose monitor (CGM) or insulin pump. To evaluate the effects of this, a yearly questionnaire will be sent to these patients for the next five years. Data for the different outcomes according to the list of aims below wil be extracted from patient records and "Danmarks statistik" and the be analyzed according to the results from the questionnaires.

Rationale

To test if a systematic prioritizing of CGM as first line technology treatment will result in

1. Lower HbA1c (primary endpoint)

2. Less fear of hypoglycemia

3. Less hypoglycemic and diabetic ketoacidotic events

4. Better health and diabetes related QoL

5. A reduction in economic expences related to blood glucose strips and societal perspective

Description of the cohort

All patients with type 1 diabetes in the Region of Southern Denmark registered at an out patient clinic.

Data and biological material

Questionnaire data and data extraction from patient records and "Danmarks statistik"

Collaborating researchers and departments

Department of Medicine, Souhtwestern Hospital

Clinical Professor Claus Bogh juhl